Screening of Medicines for Malaria Venture Open Boxes Identifies Potent SARS-CoV‑2 Papain-like Protease (PLpro) Inhibitors.

Saved in:
Bibliographic Details
Title: Screening of Medicines for Malaria Venture Open Boxes Identifies Potent SARS-CoV‑2 Papain-like Protease (PLpro) Inhibitors.
Authors: Gawriljuk VO; São Carlos Institute of Physics, University of São Paulo, Av. João Dagnone, 1100Jardim Santa Angelina, São Carlos 13563-120, Brazil., Noske GD; São Carlos Institute of Physics, University of São Paulo, Av. João Dagnone, 1100Jardim Santa Angelina, São Carlos 13563-120, Brazil., Fernandes RS; São Carlos Institute of Physics, University of São Paulo, Av. João Dagnone, 1100Jardim Santa Angelina, São Carlos 13563-120, Brazil., Nakamura AM; São Carlos Institute of Physics, University of São Paulo, Av. João Dagnone, 1100Jardim Santa Angelina, São Carlos 13563-120, Brazil., Freire MCLC; São Carlos Institute of Physics, University of São Paulo, Av. João Dagnone, 1100Jardim Santa Angelina, São Carlos 13563-120, Brazil., Godoy MO; São Carlos Institute of Physics, University of São Paulo, Av. João Dagnone, 1100Jardim Santa Angelina, São Carlos 13563-120, Brazil., Bonatto V; São Carlos Institute of Physics, University of São Paulo, Av. João Dagnone, 1100Jardim Santa Angelina, São Carlos 13563-120, Brazil., Chelucci R; São Carlos Institute of Physics, University of São Paulo, Av. João Dagnone, 1100Jardim Santa Angelina, São Carlos 13563-120, Brazil., Andricopulo A; São Carlos Institute of Physics, University of São Paulo, Av. João Dagnone, 1100Jardim Santa Angelina, São Carlos 13563-120, Brazil., Bakowski MA; Calibr-Skaggs Institute for Innovative Medicine, La Jolla, California 92037, United States., Wolff KC; Calibr-Skaggs Institute for Innovative Medicine, La Jolla, California 92037, United States., Riva L; Calibr-Skaggs Institute for Innovative Medicine, La Jolla, California 92037, United States., Burrows JN; MMV Medicines for Malaria Venture, ICC, Route de Pré-Bois 20, Geneva 1215, Switzerland., Wells TNC; MMV Medicines for Malaria Venture, ICC, Route de Pré-Bois 20, Geneva 1215, Switzerland., Laleu B; MMV Medicines for Malaria Venture, ICC, Route de Pré-Bois 20, Geneva 1215, Switzerland., Martins R; Department of Cellular and Molecular Biology and Pathogenic Bioagents, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14040-900, Brazil.; Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão PretoFCFRP, Universidade de São PauloUSP, Ribeirão Preto, São Paulo 14040-903, Brazil., Souza JP; Department of Cellular and Molecular Biology and Pathogenic Bioagents, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14040-900, Brazil., Arruda E; Department of Cellular and Molecular Biology and Pathogenic Bioagents, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14040-900, Brazil., Samby K; Johnson and Johnson Pvt., Ltd., Gurgaon 122003, India., Laskar S; TCG Lifesciences, West Bengal 700091, India., Guido RVC; São Carlos Institute of Physics, University of São Paulo, Av. João Dagnone, 1100Jardim Santa Angelina, São Carlos 13563-120, Brazil., Oliva G; São Carlos Institute of Physics, University of São Paulo, Av. João Dagnone, 1100Jardim Santa Angelina, São Carlos 13563-120, Brazil., Godoy AS; São Carlos Institute of Physics, University of São Paulo, Av. João Dagnone, 1100Jardim Santa Angelina, São Carlos 13563-120, Brazil.; MMV Medicines for Malaria Venture, ICC, Route de Pré-Bois 20, Geneva 1215, Switzerland.
Source: ACS omega [ACS Omega] 2025 Sep 11; Vol. 10 (37), pp. 42711-42724. Date of Electronic Publication: 2025 Sep 11 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101691658 Publication Model: eCollection Cited Medium: Internet ISSN: 2470-1343 (Electronic) Linking ISSN: 24701343 NLM ISO Abbreviation: ACS Omega Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2470-1343
DOI:10.1021/acsomega.5c04858